GlobeNewswire: Societal CDMO, Inc. Contains the last 10 of 265 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T20:19:29ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/02/28/2837478/0/en/Societal-CDMO-Enters-Into-Definitive-Agreement-to-be-Acquired-by-CoreRx-Inc.html?f=22&fvtc=4&fvtv=21138Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.2024-02-28T21:29:04Z<![CDATA[Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging]]>https://www.globenewswire.com/news-release/2024/02/01/2821861/0/en/Societal-CDMO-and-Benuvia-Sign-Co-Marketing-Agreement-Designed-to-Promote-Complementary-CDMO-and-API-Manufacturing-Services-to-Drug-Developers.html?f=22&fvtc=4&fvtv=21138Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers2024-02-01T12:00:28Z<![CDATA[Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets]]>https://www.globenewswire.com/news-release/2024/01/05/2804875/0/en/Societal-CDMO-Reports-Inducement-Grants-for-New-Staff.html?f=22&fvtc=4&fvtv=21138Societal CDMO Reports Inducement Grants for New Staff2024-01-05T21:05:12Z<![CDATA[SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the addition of new employees to fill open roles throughout the organization.]]>https://www.globenewswire.com/news-release/2023/11/08/2776715/0/en/Societal-CDMO-Reports-Third-Quarter-2023-Financial-Results.html?f=22&fvtc=4&fvtv=21138Societal CDMO Reports Third Quarter 2023 Financial Results2023-11-08T21:05:20Z<![CDATA[Recorded Q3 Revenue of $23.6 Million]]>https://www.globenewswire.com/news-release/2023/11/01/2771727/0/en/Societal-CDMO-to-Report-Financial-Results-for-Third-Quarter-2023-on-November-8-2023.html?f=22&fvtc=4&fvtv=21138Societal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 20232023-11-01T20:05:49Z<![CDATA[Webcast Scheduled for Wednesday, November 8, 2023, at 4:30 p.m. Eastern Webcast Scheduled for Wednesday, November 8, 2023, at 4:30 p.m. Eastern]]>https://www.globenewswire.com/news-release/2023/10/05/2755761/0/en/Societal-CDMO-Reports-Inducement-Grants-for-New-Staff.html?f=22&fvtc=4&fvtv=21138Societal CDMO Reports Inducement Grants for New Staff2023-10-05T20:05:03Z<![CDATA[SAN DIEGO and GAINESVILLE, Ga., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the addition of new employees to fill open roles throughout the organization.]]>https://www.globenewswire.com/news-release/2023/09/25/2748982/0/en/Societal-CDMO-to-Participate-in-RBC-Capital-Markets-Virtual-CDMO-Conference.html?f=22&fvtc=4&fvtv=21138Societal CDMO to Participate in RBC Capital Markets Virtual CDMO Conference2023-09-25T20:05:36Z<![CDATA[SAN DIEGO and GAINESVILLE, Ga., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will participate at the RBC Capital Markets Virtual CDMO Conference. David Enloe, chief executive officer, will be the featured speaker in a fireside chat at the conference, which will take place October 2-3, 2023.]]>https://www.globenewswire.com/news-release/2023/09/20/2746855/0/en/Societal-CDMO-Announces-Corporate-Restructuring.html?f=22&fvtc=4&fvtv=21138Societal CDMO Announces Corporate Restructuring2023-09-20T20:05:38Z<![CDATA[Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and Increase Operational Efficiency in Areas of Historical Strength Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and Increase Operational Efficiency in Areas of Historical Strength]]>https://www.globenewswire.com/news-release/2023/09/07/2739182/0/en/Societal-CDMO-Secures-Project-Expansion-Agreements-With-Several-Existing-Customers.html?f=22&fvtc=4&fvtv=21138Societal CDMO Secures Project Expansion Agreements With Several Existing Customers2023-09-07T11:00:26Z<![CDATA[Additional Work Across Facilities in California and Georgia to Include Analytical Method Development and Validation, Dissolution Testing, and Manufacturing of Prototype, Surrogate, and Engineering Batches Additional Work Across Facilities in California and Georgia to Include Analytical Method Development and Validation, Dissolution Testing, and Manufacturing of Prototype, Surrogate, and Engineering Batches]]>https://www.globenewswire.com/news-release/2023/08/29/2733259/0/en/Societal-CDMO-Announces-Closing-of-8-3-Million-Public-Offering-of-Common-Stock.html?f=22&fvtc=4&fvtv=21138Societal CDMO Announces Closing of $8.3 Million Public Offering of Common Stock2023-08-29T11:00:39Z<![CDATA[SAN DIEGO and GAINESVILLE, Ga., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (“CDMO”) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company closed its previously announced underwritten public offering of 20,750,000 shares of its common stock (or common stock equivalents) at a public offering price of $0.40 per share of common stock (or common stock equivalent) on Monday, August 28, 2023. The gross proceeds of the offering were $8.3 million, before underwriting discounts and commissions and offering expenses. Societal intends to use the net proceeds from the offering for general corporate purposes.]]>